174603-42-0 Usage
Uses
Used in Pharmaceutical Industry:
6-FLUORO-4-METHYLINDAN-1-ONE is used as a chemical intermediate for the synthesis of pharmaceutical compounds due to its unique structure and fluorine substitution. The presence of fluorine can enhance the lipophilicity, metabolic stability, and bioavailability of the resulting drug molecules, making it a valuable component in the development of new medications.
Used in Research and Development:
In the research industry, 6-FLUORO-4-METHYLINDAN-1-ONE serves as a key building block for the synthesis of complex organic molecules and fluorine-containing compounds. Its reactivity and specific properties make it useful for exploring novel chemical reactions and developing new synthetic pathways, contributing to the advancement of organic chemistry and related fields.
Used in Organic Synthesis:
6-FLUORO-4-METHYLINDAN-1-ONE is utilized as a precursor in organic synthesis for the preparation of other fluorine-containing compounds. Its unique structure allows for further functionalization and modification, enabling the creation of a wide range of organic molecules with diverse applications in various industries, including materials science, agrochemicals, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 174603-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,6,0 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 174603-42:
(8*1)+(7*7)+(6*4)+(5*6)+(4*0)+(3*3)+(2*4)+(1*2)=130
130 % 10 = 0
So 174603-42-0 is a valid CAS Registry Number.
174603-42-0Relevant articles and documents
3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE
-
Paragraph 1440-1442, (2015/04/15)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 3-aryl-5-substituted-2H-isoquinolin-1-one compounds that, inter alia, inhibit PARP (e.g., PARP1, TNKS1, TNKS2, etc.
Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activity
Musso, David L.,Orr, G. Faye,Cochran, Felicia R.,Kelley, James L.,Selph, Jeffrey L.,Rigdon, Greg C.,Cooper, Barrett R.,Jones, Michael L.
, p. 409 - 416 (2007/10/03)
Extension of the structure-activity relationship studies that led to the discovery of the nonsedating potent muscle relaxant, antiinflammatory, and analgesic agent (E)-2-(4,6-difluoro-1-indanylidene)acetamide, 1, has given rise to (E)-2-(4-chloro-6-fluoro
